Regeneron Pharmaceuticals Inc. buy StockNews.com
Summary
This prediction is currently active. With a performance of -2.71%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 13.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w |
---|---|
Regeneron Pharmaceuticals Inc. | -1.902% |
iShares Core DAX® | 2.594% |
iShares Nasdaq 100 | 3.553% |
iShares Nikkei 225® | 0.687% |
iShares S&P 500 | 2.209% |
Comments by StockNews_com for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Stopped prediction by StockNews_com for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
20.04.24
20.04.25
22:26
Regeneron Pharmaceuticals Inc.
06.01.24
06.01.25
22:26
Regeneron Pharmaceuticals Inc.
28.12.23
28.12.24
22:26
Regeneron Pharmaceuticals Inc.
20.12.23
20.12.24
22:26
Regeneron Pharmaceuticals Inc.
20.08.23
20.08.24
22:26
Regeneron Pharmaceuticals Inc.
12.08.23
12.08.24
22:26
Regeneron Pharmaceuticals Inc.
05.08.23
05.08.24
22:26